Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+1.45%
1,082.80
+15.44
+1.45%
—1,067.361,073.631,085.941,073.63——
SIXC
Communications
SIXC
Communications
SIXC
+0.05%
603.77
+0.29
+0.05%
—603.48603.48606.47601.43——
SIXE
Energy
SIXE
Energy
SIXE
-2.71%
1,211.19
-33.74
-2.71%
—1,244.931,238.101,246.591,210.94——
SIXI
Industrials
SIXI
Industrials
SIXI
+1.48%
1,755.99
+25.61
+1.48%
—1,730.381,737.301,760.621,737.30——
SIXM
Financials
SIXM
Financials
SIXM
-0.15%
638.51
-0.96
-0.15%
—639.47639.46643.01636.91——
SIXR
Staples
SIXR
Staples
SIXR
-1.40%
842.96
-11.99
-1.40%
—854.95854.97855.66842.13——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.33%
219.28
+0.72
+0.33%
—218.56218.56220.16218.53——
SIXT
Technology
SIXT
Technology
SIXT
+2.66%
3,728.35
+96.76
+2.66%
—3,631.593,687.983,744.373,675.71——
SIXU
Utilities
SIXU
Utilities
SIXU
-0.03%
915.48
-0.29
-0.03%
—915.77917.87921.16915.35——
SIXV
Health care
SIXV
Health care
SIXV
-1.02%
1,497.36
-15.45
-1.02%
—1,512.811,514.561,514.951,497.36——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.21%
2,413.17
+4.96
+0.21%
—2,408.212,418.112,427.232,398.16——
Q4 2026 earnings • released • EPS beat +1.31% • Revenue beat +5.45%
See results
JUBLPHARMA:NSE
Jubilant Pharmova Ltd
₹989.75
-1.74%
(-17.50) 1D
May 26, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for JUBLPHARMA...
Open
₹1,002.70
High
₹1,002.75
Low
₹983.35
Mkt. cap
156.76B
Avg. vol.
127.80K
Volume
115.83K
Dividend
0.51%
Quarterly dividend
₹1.25
Ex-dividend date
Jul 24, 2026
P/E ratio
36.35
52-wk high
₹1,248.00
52-wk low
₹786.05
EPS
₹27.23
No. of employees
6K
News stories
From sources across the web
About Jubilant Pharmova Ltd
CEO-
Employees5.55K
Founded1978
HeadquartersNoida, Uttar Pradesh, India
SectorPharmaceutical industry
Websitejubilantpharmova.com
Last report
May 22, 2026
Fiscal period
Q4 2026
EPS / Est. (INR)
₹8.10 / ₹8.00
+1.31%beat
Revenue / Est. (INR)
23.14B / 21.94B
+5.45%beat
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
19.01B
19.66B
21.22B
23.14B
Cost of goods sold
6.18B
5.96B
7.16B
7.13B
Cost of revenue
6.18B
5.96B
7.16B
7.13B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.91B
6.36B
7.06B
7.67B
Operating expense
10.91B
11.33B
12.37B
13.54B
Total operating expenses
17.09B
17.30B
19.54B
20.68B
Operating income
1.92B
2.37B
1.69B
2.46B
Other non operating income
120.00M
98.00M
205.00M
-
EBT including unusual items
1.54B
1.90B
934.00M
1.76B
EBT excluding unusual items
1.54B
1.96B
1.33B
1.90B
Income tax expense
519.00M
704.00M
376.00M
567.00M
Effective tax rate
33.61%
36.99%
40.26%
32.22%
Other operating expenses
4.02B
3.92B
4.10B
4.70B
Net income
1.03B
1.20B
559.00M
1.19B
Net profit margin
5.41%
6.12%
2.63%
5.16%
Earnings per share
-
7.85
5.01
8.10
Interest and investment income
-
-
-
-
Interest expense
-490.00M
-502.00M
-561.00M
-565.00M
Net interest expenses
-490.00M
-502.00M
-561.00M
-565.00M
Depreciation and amortization charges
981.00M
1.05B
1.21B
1.17B
EBITDA
2.84B
3.38B
2.30B
3.56B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer